Pharmaceutical Technology on MSN
Rare paediatric disease voucher programme makes long-awaited US return
After more than a year out in the cold, the programme’s reauthorisation is a boost for rare disease therapy developers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results